Mankind Pharma shares jump 8% as Q2 profit rises 38% to Rs 716 croreMankind Pharma shares jumped nearly 8% after the company reported a 38% year-on-year rise in Q2 profit to Rs 716 crore. Revenue grew 17%, s...
5 stocks with consistent score improvement and upside potential of up to 29 % in 1 year, according to analystsLook at how the market treated the stock of a large FMCG stock – one the best wealth creators of the past – just because it mentioned the r...
These large- and mid-cap stocks can give more than 20% return in 1 year, according to analystsThe next few weeks are critical, and one should not be in a hurry to make market-related decisions. Better to be cautious – to wait and wat...
Long-term investing is about looking beyond narratives, including AI: 5 large-caps with an upside potential of up to 24%As we see a recovery in the market, it is good to be cognizant of the fact that more than the narratives on the street, it is the earnings ...
5 stocks with consistent score improvement and upside potential of up to 34% in 1 year, according to analystsGiven the current global and domestic situation, the chances are that the volatility quotient in the market will remain high. So, the best ...
When nothing is cheap, winners may come from any corner: 19 stocks with downside to upside potential of -28% to plus 22%Because each pharma company took a different road, they no longer rise and fall together. Where any one of them stands in 10 years depends ...
Dabur expects double-digit Q2 revenue growth on strong India FMCG, overseas demandDabur India expects consolidated revenue to grow in double digits in the September quarter, supported by strong performance across its Indi...
Dabur shares rise 4% as firm sees double-digit Q2 growth; FMCG set for strong performanceDabur shares rose sharply on Tuesday after the FMCG major projected double-digit consolidated revenue and PAT growth in Q2FY27. Its India F...
Dabur India expects double-digit revenue growth in Q2 FY27Dabur India anticipates strong double-digit growth in its consolidated revenues and India FMCG business for the upcoming quarter. Demand co...
How rising US bond yields and dollar recovery is weighing on goldGold is facing renewed selling pressure after the US Fed’s rate hike, with higher Treasury yields and a stronger dollar reducing the appeal...
Ashok Leyland: A stronger balance sheet inside a business that will always remain cyclicalQuarterly numbers tell you what happened. But they do not always tell you why it happened. In commercial vehicles, demand can change becaus...
Triple shock rattles India’s FMCG basket as 68% of categories lose volumeIndia's FMCG market is experiencing significant challenges as higher costs and rural income pressures affect consumption patterns, NielsenI...
Bitcoin whales add 113,950 BTC USD worth $9.6 billion in 10 weeks - is this crypto rally being fueled by big buyers?Bitcoin wallets holding between 100 and 1,000 BTC have accumulated over $9.6 billion in recent weeks. This increase occurred alongside Bitc...
Short-term headwind? Yes. But the structure stays intact: 5 large-cap stocks with upside potential of up to 19%Wise men on the street will tell you it is foolish to try and time the market. And attempting to do so in the midst of a raging war is prob...
Rupee closes at near 2-month high of 94.95 to the dollarOn Tuesday, the Indian rupee achieved its strongest close in nearly two months, settling at 94.95. Factors such as dollar offers and centra...
India's over-the-counter drugs market to hit Rs 98,000 crore by 2030: ReportAn EY report estimated that India's OTC market, valued around Rs 47,000 crore in 2024, is projected to grow to Rs 98,000 crore around 13 pe...
- Mankind forays into OTC market
Formulation drug maker Mankind Pharma has ventured into Rs 2,000 crore over-the-counter (OTC) market and will launch seven products in the ...